The NEONATE score predicts freedom from interstage mortality or transplant in a modern cohort.

Humera AhmedJeffrey B AndersonKatherine E BatesCarole M LannonDavid W Brownnull null

Published in: Cardiology in the young (2023)

In a modern cohort of patients with single ventricle CHD and aortic arch hypoplasia, the NEONATE score remains useful at discharge post-Stage 1 palliation to predict freedom from interstage mortality or heart transplant.

Keyphrases

cardiovascular events
risk factors
heart failure
pulmonary artery
mitral valve
cardiovascular disease
coronary artery disease
coronary artery
left ventricular
congenital heart disease